EUVIMEDEUVIMED entdecken
Open Access

Pan-Cancer Analysis of Enhancer-Induced PAN3-AS1 and Experimental Validation as a WFDC13-Promoting Factor in Colon Cancer

Xu Guo, Yanan Yu, Xiaolin Ma, Yuanjie Cai

Oncology Research · 2026

DOI: 10.32604/or.2025.069274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Xu Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Zhejiang Hospital, Hangzhou, 310013, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, RNA, Long Noncoding. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsRNA, Long NoncodingHumansGene Expression Regulation, NeoplasticCell ProliferationBiomarkers, TumorPrognosisTumor MicroenvironmentMicroRNAsCell Line, TumorMolecular Docking SimulationComputational Biology

Stichwörter der Autor:innen

PAN3-AS1biomarkerenhancerimmunotherapypan-cancer

Substanzen

RNA, Long NoncodingBiomarkers, TumorMicroRNAs

Autor:innen und Institutionen

  • Department of Breast Surgery, Zhejiang Hospital, Hangzhou, 310013, China.
  • Clinical Research Center, Affiliated Hospital of Shandong Second Medical University, Weifang, 261041, China.
  • Department of Oncology, Affiliated Hospital of Shandong Second Medical University, Weifang, 261041, China.

Zitieren

APA

Guo, X., Yu, Y., Ma, X., & Cai, Y. (2026). Pan-Cancer Analysis of Enhancer-Induced PAN3-AS1 and Experimental Validation as a WFDC13-Promoting Factor in Colon Cancer. Oncology Research. https://doi.org/10.32604/or.2025.069274

Vancouver

Guo X, Yu Y, Ma X, Cai Y. Pan-Cancer Analysis of Enhancer-Induced PAN3-AS1 and Experimental Validation as a WFDC13-Promoting Factor in Colon Cancer. Oncology Research. 2026. doi:10.32604/or.2025.069274

BibTeX
@article{Guo2026,
  author = {Guo, Xu and Yu, Yanan and Ma, Xiaolin and Cai, Yuanjie},
  title = {Pan-Cancer Analysis of Enhancer-Induced PAN3-AS1 and Experimental Validation as a WFDC13-Promoting Factor in Colon Cancer},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2025.069274}
}
Kostenlos starten →